Total Payments
$7,295
2024 Payments
$2,474
Companies
27
Transactions
306
Medicare Patients
12,120
Medicare Billing
$982,413
Payment Breakdown by Category
Food & Beverage$7,042 (96.5%)
Education$253.15 (3.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,042 | 301 | 96.5% |
| Education | $253.15 | 5 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,255 | 104 | $0 (2024) |
| Janssen Biotech, Inc. | $939.22 | 35 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $552.88 | 39 | $0 (2024) |
| GENZYME CORPORATION | $468.46 | 14 | $0 (2024) |
| PFIZER INC. | $458.42 | 15 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $350.78 | 9 | $0 (2024) |
| Lilly USA, LLC | $332.07 | 13 | $0 (2024) |
| Amgen Inc. | $319.04 | 12 | $0 (2024) |
| UCB, Inc. | $273.50 | 10 | $0 (2024) |
| Genentech USA, Inc. | $147.96 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,474 | 110 | ABBVIE INC. ($866.91) |
| 2023 | $1,649 | 65 | AbbVie Inc. ($528.03) |
| 2022 | $1,139 | 55 | ABBVIE INC. ($425.07) |
| 2021 | $745.20 | 35 | GENZYME CORPORATION ($292.48) |
| 2020 | $21.08 | 1 | Lilly USA, LLC ($21.08) |
| 2019 | $564.16 | 18 | PFIZER INC. ($121.25) |
| 2018 | $612.68 | 21 | AbbVie, Inc. ($206.75) |
| 2017 | $90.09 | 1 | PFIZER INC. ($90.09) |
All Payment Transactions
306 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Immunology | ||||||
| 12/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Inflammation & Immunology | ||||||
| 12/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Immunology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| Category: Immunology | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: IMMUNOLOGY | ||||||
| 11/29/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $36.09 | General |
| Category: Immunology | ||||||
| 11/15/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Immunology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Immunology | ||||||
| 11/14/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $8.49 | General |
| Category: Immunology | ||||||
| 11/08/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Dermatology | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $2.53 | General |
| Category: Dermatology | ||||||
| 11/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $1.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.19 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $17.49 | General |
| Category: DERMATOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $1.12 | General |
| Category: DERMATOLOGY | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 3,715 | 7,785 | $806,420 | $308,129 |
| 2022 | 23 | 3,756 | 8,037 | $822,494 | $308,590 |
| 2021 | 20 | 2,716 | 5,476 | $576,032 | $221,444 |
| 2020 | 14 | 1,933 | 3,640 | $386,855 | $144,251 |
Total Patients
12,120
Total Services
24,938
Medicare Billing
$982,413
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 568 | 713 | $114,080 | $45,537 | 39.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 353 | 480 | $108,000 | $45,329 | 42.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 170 | 244 | $65,880 | $33,981 | 51.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 547 | 711 | $92,430 | $31,989 | 34.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 657 | 1,003 | $80,765 | $30,210 | 37.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 258 | 295 | $64,900 | $23,728 | 36.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 470 | 3,564 | $60,588 | $20,700 | 34.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 63 | 66 | $42,570 | $16,309 | 38.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 143 | 153 | $35,955 | $14,211 | 39.5% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2023 | 20 | 27 | $18,900 | $8,150 | 43.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 102 | 102 | $22,950 | $7,630 | 33.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $20,638 | $6,341 | 30.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 48 | 50 | $26,250 | $5,920 | 22.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 65 | 109 | $13,080 | $4,761 | 36.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 75 | 82 | $7,544 | $3,450 | 45.7% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2023 | 20 | 27 | $8,100 | $3,169 | 39.1% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 22 | 23 | $13,800 | $2,957 | 21.4% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 12 | 12 | $3,300 | $1,354 | 41.0% |
| 69100 | Biopsy of ear | Office | 2023 | 18 | 18 | $3,600 | $1,263 | 35.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 16 | 16 | $2,480 | $875.61 | 35.3% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 27 | 29 | $610.00 | $263.48 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 402 | 519 | $116,775 | $46,018 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 578 | 724 | $112,855 | $45,441 | 40.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 627 | 788 | $102,440 | $34,260 | 33.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 172 | 232 | $62,640 | $31,551 | 50.4% |
About Brianne Dickey
Brianne Dickey is a Dermatology healthcare provider based in Santa Rosa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2013. The National Provider Identifier (NPI) number assigned to this provider is 1760725394.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brianne Dickey has received a total of $7,295 in payments from pharmaceutical and medical device companies, with $2,474 received in 2024. These payments were reported across 306 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($7,042).
As a Medicare-enrolled provider, Dickey has provided services to 12,120 Medicare beneficiaries, totaling 24,938 services with total Medicare billing of $982,413. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Santa Rosa, CA
- Active Since 04/02/2013
- Last Updated 03/17/2018
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1760725394
Products in Payments
- SKYRIZI (Biological) $1,232
- DUPIXENT (Biological) $685.69
- RINVOQ (Biological) $592.37
- TREMFYA (Drug) $573.59
- TALTZ (Drug) $332.07
- Otezla (Drug) $319.04
- EUCRISA (Drug) $259.14
- Bimzelx (Biological) $256.29
- COSENTYX (Biological) $246.46
- Humira (Biological) $206.75
- REMICADE (Biological) $184.76
- CIBINQO (Drug) $181.91
- Tremfya (Drug) $174.05
- COSENTYX (Drug) $168.06
- HUMIRA (Biological) $147.02
- Sotyktu (Drug) $140.17
- Erivedge (Biological) $132.75
- LIBTAYO (Biological) $118.81
- SILIQ (Drug) $117.39
- ADBRY (Biological) $112.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Santa Rosa
Dr. Henry Degroot, Md, MD
Dermatology — Payments: $13,709
Dermatology $13,709
Dr. Khanh Truong, M.d, M.D
Dermatology — Payments: $10,033
Dermatology $10,033
Albert Peng, M.d, M.D
Dermatology — Payments: $9,118
Dermatology $9,118
Judith Groves, M.d, M.D
Dermatology — Payments: $7,893
Dermatology $7,893
Ligaya Park, D.o, D.O
Dermatology — Payments: $6,490
Dermatology $6,490
Dr. William Kivett, Md, Faad, Facs, MD, FAAD, FACS
Dermatology — Payments: $4,083
Dermatology $4,083